Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S.

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Dexcom announced today that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA.

BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity ...

Luna Diabetes announced that it launched its pivotal trial for Luna, the company's miniature automated insulin delivery ...

Senseonics (NYSE:SENS) announced today that it entered into a definitive agreement to offer $16 million in common stock.

January AI today unveiled new advancements to its AI-driven metabolic health app that helps users monitor and take control of ...

ViCentra announced that it received CE mark approval for its Kaleido insulin pump under European Medical Device Regulation ...

Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer ...